15 employees
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
2018
$63M
from 3 investors over 3 rounds
Aristea Therapeutics raised $63M on July 27, 2021
Investors: Arena Pharmaceuticals, Inc. and Novo Holdings
Aristea Therapeutics raised $15M on December 18, 2018
Investors: Novo Holdings